EcoR1 Capital, LLC - Q3 2014 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2014
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KURA ONCOLOGY ORD32Q3 202310.5%
XENCOR ORD25Q3 202312.6%
ASSEMBLY BIOSCIENCES ORD23Q3 202019.0%
FIBROGEN ORD22Q1 202012.4%
PROTHENA ORD20Q3 202328.0%
IRONWOOD PHARMA CL A ORD20Q1 202013.9%
GALAPAGOS NV SPON ADR19Q3 202312.0%
MORPHIC HOLDING ORD18Q3 20238.5%
ARCUS BIOSCIENCES ORD17Q1 20227.1%
ANAPTYSBIO INC16Q3 20238.3%

View EcoR1 Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
EcoR1 Capital, LLC Q3 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Mersana Therapeutics, Inc.July 27, 202319,364,68816.9%
TScan Therapeutics, Inc.June 05, 20235,000,00011.7%
2seventy bio, Inc.February 14, 20231,143,4943.0%
Avidity Biosciences, Inc.Sold outFebruary 14, 202300.0%
Surface Oncology, Inc.February 13, 20233,924,7136.5%
Akouos, Inc.Sold outFebruary 10, 202300.0%
Alector, Inc.February 10, 20234,056,5484.9%
Arcus Biosciences, Inc.Sold outFebruary 10, 202300.0%
Gritstone bio, Inc.Sold outFebruary 10, 202300.0%
Ovid Therapeutics Inc.February 10, 20236,117,4008.7%

View EcoR1 Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-08
32024-03-26
SC 13G/A2024-03-26
SC 13G2024-03-11
SC 13D2024-02-22
SC 13G2024-02-16
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View EcoR1 Capital, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export EcoR1 Capital, LLC's holdings

CSVXLS